Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Canada's Procurement Minister Anita Anand with a shipment from South Africa of the Johnson & Johnson vaccine against COVID-19, at Toronto Pearson Airport in Ontario, on April 28, 2021.

CARLOS OSORIO/Reuters

April was a brutal month in Canada’s battle against the COVID-19 pandemic. Not even the Atlantic provinces, which had until then contained the spread of the disease to a remarkable degree, escaped unscathed. In Nova Scotia, for instance, a late-April surge in cases led to the return of bans on travel and indoor dining at restaurants, and the closing of schools and non-essential businesses.

But along with that setback, and a rise in cases in the rest of the country that has pushed some provincial health care systems to the brink, there was also an outbreak of positive news in the final days of an unlamented month.

The biggest news was about vaccines: They’re here, and they work.

Story continues below advertisement

A dose of hope: Here’s why you might get the COVID-19 vaccination sooner than you think

Tracking Canada’s COVID-19 vaccine rollout plans: A continuing guide

Coronavirus tracker: How many COVID-19 cases are there in Canada and worldwide? The latest maps and charts

That the vaccines are effective has never been more clear than in the success Ontario and Quebec have had reducing deaths in long-term care homes. The killing fields of the first and second pandemic waves now rarely see COVID-19 fatalities, thanks to an all-out effort to vaccinate residents and staff in January and February. Ontario recorded just four LTC resident deaths in April.

The vaccines’ worth is also being seen in real-world testing in countries that have achieved high rates of vaccination.

In Britain, where 70 per cent of the population has received one dose of a vaccine, Public Health England said on Friday that the total number of cases in the country, which has been dropping steadily since January, fell by another 40 per cent in a single week at the end of April.

In Israel, where 56 per cent of the population has been fully vaccinated, the rate of infection has dropped from a peak of about 10,000 a day to as low as 140. Life has largely returned to normal.

Here in Canada, by the end of April, 34.5 per cent of the population had been given at least one dose of vaccine. The number of people in hospital and in intensive care was still high, but the rise in cases appeared to have plateaued.

And now vaccines are rolling in. Almost two million arrived last week, and more are on the way in May: two million doses a week of Pfizer-BioNTech, at least one million Moderna shots, and possibly more Oxford-AstraZeneca.

That’s enough doses to vaccinate another quarter of the population, or more, by the end of May. Canada’s two biggest provinces announced last week that everyone over the age of 18 will be eligible for a shot by the end of the month.

Story continues below advertisement

There were other signs of hope. In Ontario, the government will double down on vaccinations in hard-hit areas, mostly in Greater Toronto, for the next two weeks. In Vancouver, a concerted effort to vaccinate people in the hard-luck Downtown Eastside neighbourhood has dramatically reduced new cases there. And in Toronto, the city will start installing the infrastructure for curb lane patios in anticipation of outdoor dining once again becoming possible.

All of this is beyond welcome. But while Canada is making progress against the pandemic, we have not yet beaten it. There are still many things that could go wrong.

Most notably, the provinces could take their foot off the brake too quickly and repeat their errors of February and March, when they lifted restrictions just as new variants were on the rise.

It is critical that robust public health measures remain for some time. They may even need to be reinforced in places, such as Alberta, where case counts are surging. The rate of infections has a long way to fall, and vaccinations a long way to rise, before we’re ready for a safe and sustainable reopening.

Owing to the danger of new and unknown variants, the necessary measures include strong border screening – stronger than Ottawa is currently enforcing.

As for the provinces, they have to ensure that more shots are being focused on the hottest areas with the highest case counts. They also have to make sure that a shot is as easy as possible to get, so nobody has an excuse to avoid getting one.

Story continues below advertisement

That means finding multiple ways to get jabs into arms, from mass clinics to community pop-ups to going straight to people’s doors. It means doing everything to push the first-shot rate to close to 100 per cent of adults.

It also means preparing for the next challenge, which is getting everyone a second shot. April had one last bit of bad news on Friday, with a new British study saying that a single dose of the Pfizer vaccine still leaves people vulnerable to COVID-19 variants.

Canada made progress in April. May can bring a lot more.

Keep your Opinions sharp and informed. Get the Opinion newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies